XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

ValueSets

28,490 resources

By Version

R2: 0
R2B: 0
R3: 1,139
R4: 23,323
R4B: 240
R5: 3,759
R6: 29

By Authority

none: 8,388
hl7: 17,520
ihe: 218
national: 1,308
who: 1,056

By Realm

none: 5,628
au: 87
be: 108
br: 66
ca: 242
ch: 396
cl: 148
cr: 11
cz: 46
de: 679
dk: 468
ee: 66
eu: 347
fi: 4
fr: 810
il: 140
in: 48
it: 92
jp: 71
nl: 943
no: 6
nz: 55
pt: 11
se: 10
tw: 160
uk: 38
us: 12,841
uv: 4,904
vn: 23
other: 5

Start Prev Rows 5600 - 5800 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth	Source(s)
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.212	Hemorrhagic Stroke	active	2021-02	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.213	INR	active	2021-02	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.214	Intermittent pneumatic compression devices	active	2023-01	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.215	LDLc	active	2021-02	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.218	Unfractionated Heparin	active	2021-02	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.219	Low Molecular Weight Heparin for VTE Prophylaxis	active	2023-01	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.222	Intravenous route	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.223	Subcutaneous route	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.226	Thrombolytic tPA Therapy	active	2021-02	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.230	Venous foot pumps	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.232	Warfarin	active	2021-02	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.234	Hemorrhagic Stroke	active	2021-02	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.235	Hemorrhagic Stroke	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.238	Carotid Intervention	active	2025-01	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.239	Carotid Intervention	active	2019-03	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.242	Atrial Ablation	active	2025-02	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.243	Atrial Ablation	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.244	Atrial Fibrillation or Flutter	active	2021-02	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.245	Atrial Fibrillation or Flutter	active	2021-02	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.246	Atrial Fibrillation or Flutter	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.247	Ischemic Stroke	active	2021-02	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.25	Single Live Birth	active	2021-06	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.251	Ischemic Stroke Embolism	active	2021-02	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.252	Ischemic Stroke Embolism	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.255	General Surgery	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.256	Graduated compression stockings	active	2024-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.257	Gynecological Surgery	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.258	Hip Fracture Surgery	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.259	Hip Replacement Surgery	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.26	Single Live Born Newborn Born in Hospital	active	2021-06	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.260	Intracranial Neurosurgery	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.261	Knee Replacement Surgery	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.263	Obstetrical or Pregnancy Related Conditions	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.264	Obstetrics VTE	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.27	Dietary Intake Other than Human Milk	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.270	Acute or Persistent Asthma	active	2022-01	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.271	Acute or Persistent Asthma	active	2022-01	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.272	Urological Surgery	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.279	Venous Thromboembolism	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.281	Labor	active	2021-06	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.282	Cesarean Birth	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.286	Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation	active	2021-06	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.288	Medical Induction of Labor	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.292	Emergency Department Visit	active	2021-06	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.294	Decision to Admit to Hospital Inpatient	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.295	Decision to Admit to Hospital Inpatient	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.296	Psychiatric/Mental Health Diagnosis	active	2024-02	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.298	Psychiatric/Mental Health Diagnosis	active	2024-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.299	Psychiatric/Mental Health Diagnosis	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.30	Human Milk	active	2025-05	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.308	Left Against Medical Advice	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.309	Patient Expired	active	2021-06	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.310	Gynecological Surgery	active	2024-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.313	Gynecological Surgery	active	2023-01	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.315	Knee Replacement Surgery	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.317	Knee Replacement Surgery	active	2023-02	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.319	Hip Replacement Surgery	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.321	Hip Replacement Surgery	active	2024-02	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.323	Hip Fracture Surgery	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.325	Hip Fracture Surgery	active	2025-02	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.328	Venous Thromboembolism	active	2025-02	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.33	Galactosemia	active	2024-04	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.330	Venous Thromboembolism	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.331	Urological Surgery	active	2024-02	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.333	Urological Surgery	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.335	Obstetrical or Pregnancy Related Conditions	active	2024-02	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.337	Obstetrical or Pregnancy Related Conditions	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.338	Obstetrics VTE	active	2021-02	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.340	Obstetrics VTE	active	2024-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.344	Intracranial Neurosurgery	active	2021-02	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.346	Intracranial Neurosurgery	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.348	General or Neuraxial Anesthesia	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.35	Galactosemia	active	2021-02	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.361	General Surgery	active	2021-04	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.365	General Surgery	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.367	Cesarean Birth	active	2021-06	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.369	Cesarean Birth	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.37	Parenteral Nutrition	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.38	Parenteral Nutrition	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.384	Medical Induction of Labor	active	2024-04	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.393	Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation	active	2024-04	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.395	Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation	active	2025-05	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.400	Low Risk	active	2024-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.401	Delivery Procedures	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.418	Classical Cesarean Birth	active	2024-04	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.419	Classical Cesarean Birth	active	2021-06	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.421	Classical Cesarean Birth	active	2022-03	us	hl7	vsac
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.422	Myomectomy	active	2024-04	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.423	Statin Allergen	active	2021-02	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.424	Nonelective Inpatient Encounter	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.473	Medical Reason For Not Providing Treatment	active	2022-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.75	Neonatal Intensive Care Unit	active	2021-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.76	Single Live born Newborn	active	2021-06	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.78	Galactosemia	active	2021-02	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.79	Parenteral Nutrition	active	2021-02	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.87	Discharge To Acute Care Facility	active	2021-06	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.117.1.7.1.93	Patient Refusal	active	2025-02	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1434.1047	Skin Melanoma pT1	active	2024-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.100	Injectable Fluorouracil	active	2020-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.101	Trastuzumab and Biosimilars	active	2023-07	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.102	Breast Cancer	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.103	HER2 Presence in Tissue	active	2020-09	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.104	Depression Screening for Adult	active	2020-10	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.105	Long Acting Opioids	active	2024-08	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.106	High Fiber Supplement or Diet Education	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.107	Standardized Assessment Tools for Dyspnea	active	2020-10	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.108	Nausea or Vomiting Assessment	active	2020-10	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.109	Pancreatic Cancer	active	2020-10	us	hl7	icd
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.110	Pancreatic Cancer	active	2023-07	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.111	Audio Visual Telehealth Encounter	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.112	Telephone Encounter	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.113	Telehealth Emergency Department or Initial Inpatient	active	2020-10	us	hl7	cms
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.114	Karnofsky Performance Status	active	2020-10	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.115	Referral to Hospice Care	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.116	Referral to Palliative Care	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.117	Assessment Scale for Dyspnea	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.118	Nausea or Vomiting Assessment	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.119	Enrollment in Hospice Care	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.120	Palliative Care	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.121	Advance Directive Including Durable Power of Attorney or Instructional	active	2020-10	us	hl7	sct
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.122	Carmustine Injectable	active	2022-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.123	Dacarbazine Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.124	Streptozocin Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.126	Alemtuzumab Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.127	Azacitidine Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.128	Bendamustine Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.129	Busulfan Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.130	Temozolomide Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.131	Thiotepa Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.132	Oxaliplatin Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.133	Romidepsin Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.134	Trabectedin Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.135	Dolasetron Oral	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.136	Dolasetron Injectable	active	2025-04	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.137	Granisetron Oral	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.138	Granisetron Transdermal	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.139	Granisetron Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.140	Ondansetron Oral	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.141	Ondansetron Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.142	Ifosfamide Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.143	Arsenic Trioxide Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.144	Netupitant Palonosetron Oral	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.145	Fosnetupitant Palonosetron Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.146	Aprepitant Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.147	Rolapitant Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.148	Dexamethasone Oral	active	2022-09	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.149	Dexamethasone Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.150	Dexamethasone Drug Implant	active	2025-04	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.151	Olanzapine Oral	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.152	Olanzapine Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.153	Idarubicin Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.154	Neurokinin 1 Receptor Antagonist Ingredient	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.155	Serotonin Receptor Antagonist Ingredient	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.156	Clofarabine Injectable	active	2021-03	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.157	Belinostat Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.158	Bortezomib Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.159	Cabazitaxel Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.160	Carfilzomib Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.161	Decitabine Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.162	Elotuzumab Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.163	Enfortumab Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.164	Eribulin Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.165	Etoposide Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.166	Inotuzumab Ozogamicin Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.167	Mitoxantrone Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.168	Moxetumomab Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.169	Necitumumab Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.170	Nelarabine Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.171	Temsirolimus Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.172	Tisagenlecleucel Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.173	Topotecan Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.178	Atezolizumab Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.179	Avelumab Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.180	Bleomycin Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.181	Cemiplimab Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.182	Cladribine Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.183	Daratumumab Injectable	active	2025-04	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.184	Durvalumab Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.185	Emapalumab Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.186	Fludarabine Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.187	Ipilimumab Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.188	Nivolumab Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.189	Pembrolizumab Injectable	active	2024-12	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.190	Polatuzumab Vedotin Injectable	active	2021-07	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.191	Pralatrexate Injectable	active	2021-07	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.192	Vincristine Injectable	active	2021-07	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.193	Methotrexate Injectable	active	2025-04	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.194	Trastuzumab Injectable	active	2025-04	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.195	Mitomycin Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.196	Brentuximab Vedotin Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.197	Doxorubicin Pegylated Liposomal Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.198	Blinatumomab Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.199	Trastuzumab Emtansine Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.200	Gemtuzumab Ozogamicin Injectable	active	2021-05	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.201	Tagraxofusp Injectable	active	2024-12	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.202	Axicabtagene Ciloleucel Injectable	active	2024-11	us	hl7	rx
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.203	BRCA1	active	2023-06	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.204	BRCA2	active	2023-06	us	hl7	loinc
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.205	BRCA1 Testing	active	2023-06	us	hl7	cpt
us.nlm.vsac	R4	2.16.840.1.113883.3.1444.3.207	Epithelial Ovarian Cancer	active	2024-08	us	hl7	sct